M

Metabiomed Co Ltd
KOSDAQ:059210

Watchlist Manager
Metabiomed Co Ltd
KOSDAQ:059210
Watchlist
Price: 4 700 KRW 2.62% Market Closed
Market Cap: 132B KRW

Operating Margin

23.4%
Current
Improving
by 9%
vs 3-y average of 14.4%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
23.4%
=
Operating Income
₩23.3B
/
Revenue
₩99.8B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
23.4%
=
Operating Income
₩23.3B
/
Revenue
₩99.8B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
Metabiomed Co Ltd
KOSDAQ:059210
122.8B KRW
Loading...
JP
Hoya Corp
TSE:7741
8.5T JPY
Loading...
CH
Alcon AG
SIX:ALC
30.5B CHF
Loading...
US
Medline Inc
NASDAQ:MDLN
35.7B USD
Loading...
DK
Coloplast A/S
CSE:COLO B
121.4B DKK
Loading...
US
Align Technology Inc
NASDAQ:ALGN
12.4B USD
Loading...
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
44.8B CNY
Loading...
UK
ConvaTec Group PLC
LSE:CTEC
4.7B GBP
Loading...
CA
Bausch + Lomb Corp
NYSE:BLCO
6.1B USD
Loading...
CH
Ypsomed Holding AG
SIX:YPSN
4.5B CHF
Loading...
JP
Asahi Intecc Co Ltd
TSE:7747
771.3B JPY
Loading...
No Stocks Found

Market Distribution

Higher than 93% of companies in Korea
Percentile
93rd
Based on 2 615 companies
93rd percentile
23.4%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

Metabiomed Co Ltd
Glance View

Market Cap
132B KRW
Industry
Health Care

Meta Biomed Co., Ltd. engages in the manufacture and sale of surgical and other medical devices. The company is headquartered in Cheongju, Chungcheongbuk-Do. The company went IPO on 2008-04-15. The firm mainly operates its business through three divisions: suture material division, dental division and bone material division. Its suture material division provides suture materials, such as polyglycolic acid (PGA) synthetic absorbable braids, polyglycolic acid-co-lactic acid (PGLA) absorbable braids, polydioxanone (PDO) synthetic absorbable monofilaments, polyglycolide-co-epsilon-caprolactone (PGCL) synthetic absorbable monofilaments and others. Its dental division provides dental materials and equipment, such as gutta percha cordless obturation systems, electronic apex locators, taper points, root canal sealers, root canal filling materials and others. Its bone materials division provides bone graft substitutes. The company also distributes dental-related products.

Intrinsic Value
16 629.73 KRW
Undervaluation 72%
Intrinsic Value
Price
M
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
23.4%
=
Operating Income
₩23.3B
/
Revenue
₩99.8B
What is Metabiomed Co Ltd's current Operating Margin?

The current Operating Margin for Metabiomed Co Ltd is 23.4%, which is above its 3-year median of 14.4%.

How has Operating Margin changed over time?

Over the last 3 years, Metabiomed Co Ltd’s Operating Margin has increased from 9% to 23.4%. During this period, it reached a low of 7.8% on Dec 31, 2022 and a high of 23.4% on Oct 30, 2025.

Back to Top